Optimal Personalised Treatment of early breast cancer using Multi-parameter Analysis
Welcome to OPTIMA, a patient driven clinical study for people with hormone sensitive early breast cancer.
OPTIMA aims to improve the way we make decisions about whom we offer chemotherapy to following surgery.